Format

Send to

Choose Destination
Cardiovasc Hematol Disord Drug Targets. 2017;17(1):52-57. doi: 10.2174/1871529X16666161220142020.

Guide of Hypertensive Crisis Pharmacotherapy.

Author information

1
Department of Internal Medicine, Texas Tech University Health Science Center at El Paso, Paul L. Foster School of Medicine, 4800 Alberta Ave, El Paso, Texas, 79905, United States.
2
Department of Obstetrics and Gynecology, Texas Tech University Health Science Center at El Paso, Paul L. Foster School of Medicine, 4800 Alberta Ave, El Paso, Texas, 79905, United States.

Abstract

BACKGROUND:

Cardiovascular diseases (CVD) are the number one cause of death globally compared to any other cause. CVD accounts for approximately 17.3 million deaths per year and are rising. Hypertension is the leading risk factor for cardiovascular diseases. Approximately, 80 million people suffer from hypertension in the U.S. While, majority of these individuals are on antihypertensive medications only 54% of individuals with hypertension are optimally controlled. Heart failure and stroke are some of the devastating complications of uncontrolled hypertension. Hypertensive crisis can be classified as either an urgency or emergency; difference between the two is the presence of end organ damage, which is noted in hypertensive emergency. Hypertensive crisis is usually treated by parenteral antihypertensive medications. The main drug classes of drugs for treatment are nitrates, calcium channel blockers, dopamine-1 agonists, adrenergic-blocking agents etc.

CONCLUSION:

In this review, we discuss approach to management of hypertensive crisis and each drug class with its physiology and complications.

KEYWORDS:

Hypertensive emergency; antihypertensive medications; cardiovascular disease; eclampsia; pregnancy

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Bentham Science Publishers Ltd.
Loading ...
Support Center